Stance Capital’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.56M Buy
+263,327
New +$3.69M 1.73% 12
2025
Q3
Sell
-227,939
Closed -$2.04M 310
2025
Q2
$2.04M Sell
227,939
-78,818
-26% -$666K 0.77% 31
2025
Q1
$2.67M Buy
306,757
+190,561
+164% +$2M 1.98% 23
2024
Q4
$1.45M Buy
+116,196
New +$1.43M 0.9% 36

Other funds holding VTRS

Stance Capital's VTRS Position: Q1 2026 in Review

Stance Capital opened a new position in Viatris (VTRS) in Q1 2026: 263,327 shares worth $3.56M. The stake represents 1.73% of the portfolio and ranks #12 among its holdings. This is a return to the name: Stance Capital previously reported a position in VTRS as recently as Q2 2025.

Stance Capital first reported a position in VTRS in Q4 2024 and has held it in 4 quarters since. 1,021 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • Stance Capital held 263,327 shares of Viatris worth $3.56M as of Q1 2026.
  • Viatris was a new Stance Capital position in Q1 2026.
  • Viatris made up 1.73% of Stance Capital's portfolio in Q1 2026, its #12 holding.
  • Stance Capital first reported a position in Viatris in Q4 2024 and has held it in 4 quarters since.
  • 1,021 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.